Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-21-002408

Options or other derivatives

  • Director acquired 206,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Clark Kenneth A · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-10-07 Grant or award : show line 1 in the form Stock Option (right to buy) +200,000 200,000 D
2021-10-07 Grant or award : show line 2 in the form Stock Option (right to buy) +6,250 206,250 D
Loading xslF345X03/form412566003_10112021.xml…